Focusing on Ab sequestration, we performed proteomics and examined the levels of three blood proteins, apolipoprotein A1 (ApoA1), transthyretin (TTR), and complement protein C3 (C3), and found that their blood levels were decreased in MCI and AD in a multicenter clinical study [2,3]. This evidence concerns the gene APOA1 and Alzheimer disease.